Live moderated video webcast event intended to provide the investment community direct access to ask their questions to

John Climaco

, Chief Executive Officer on

Tuesday, December 6


^th

at

11:00 AM ET

HOUSTON


,


Dec. 5, 2022


/PRNewswire/ —


CNS Pharmaceuticals, Inc.



(NASDAQ:

CNSP

)

(“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that


John Climaco


, Chief Executive Officer of CNS Pharmaceuticals, will participate in the

Virtual Investor “Ask the CEO” Event

on

Tuesday, December 6, 2022

at

11:00 AM ET

.

As part of the virtual event, Mr. Climaco will provide a brief presentation, followed by an interactive Q&A session. This “Ask the CEO” event is intended to provide the investment community access to ask their questions directly to Mr. Climaco. Questions can be typed in live during the event or pre-submitted by sending to

[email protected]

. Mr. Climaco will answer as many questions as possible during the event.

A

live video webcast

of the Virtual Investor “Ask the CEO” Event will be available on the

Events

page in the

Investors

section of the Company’s website (

www.cnspharma.com

). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.

About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The Company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer.

For more information, please visit

www.CNSPharma.com

, and connect with the Company on

Twitter

,

Facebook

, and

LinkedIn

.

View original content to download multimedia:

https://www.prnewswire.com/news-releases/cns-pharmaceuticals-to-participate-at-the-virtual-investor-ask-the-ceo-event-301694506.html

SOURCE CNS Pharmaceuticals, Inc.